News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Furui Subsidiary Receives U.S. Approval for Liver Test


4/17/2013 9:08:04 AM

by Richard Daverman, PhD

April 16, 2013 -- Echosens™ has been given FDA 510(k) approval to market its FibroScan® device in the US. Echosens, a French company, is wholly owned by Inner Mongolia Furui Medical Science Co. FibroScan is a noninvasive device that tests for liver fibrosis. It uses an ultrasound machine and a technology called transient elastography. The device has been marketed in Europe since 2003; the US is the last major country to approve FibroScan. More details....

Stock Symbol: (SHE: 300049)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES